Amphastar Pharmaceuticals has authorized an additional $50 million for the share buyback plan.
amphastar pharmaceuticals授权增加了5000万美元用于股票回购计划。
Amphastar Pharmaceuticals has authorized an additional $50 million for the share buyback plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.